Evidence map›Paper›PMID 42671388›Full record

ArticleThe Journal of experimental medicine2026

Functional heterogeneity and plasticity in naïve CD8 T cells drive superior effector and memory responses.

Yamato Sajiki, Satomi Ando, Charles M Perkins, Yi-Chung Huang, Katie E Smith, Carolyn M Doerning, David A Hildeman, Koichi Araki

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Yamato SajikiDivision of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID 0009-0002-7138-2926
Satomi AndoDivision of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID 0009-0008-7149-8412
Charles M PerkinsDivision of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID 0009-0008-1048-7023
Yi-Chung HuangDivision of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID 0009-0003-2755-3641
Katie E SmithComparative Medicine Division, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID 0009-0001-2046-043X
Carolyn M DoerningComparative Medicine Division, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID 0000-0002-0846-7524
David A HildemanDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.ORCID 0000-0002-0421-8483
Koichi ArakiDivision of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID 0000-0003-3478-6315

Funding

Translational Regulation of CD8 T-Cell Immunity - Transfer of R01AI139675 from EmoryR01AI139675 · NIAID · EMORY UNIVERSITY · PI ARAKI, KOICHI · 2018 to 2022
$2.3M
Vaccinology Training ProgramT32AI165396 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI Robert Wilson Frenck, PAUL W. SPEARMAN · 2022 to 2026
$1.4M
Naive CD8 T cell functional heterogeneityR01AI184466 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI Koichi Araki · 2025 to 2026
$1.3M
Cincinnati Children's Hospital Research FoundationJapan Society for the Promotion of Science 202260075NIAID NIH HHS R01 AI139675NIAID NIH HHS R01 AI184466NIAID NIH HHS T32 AI165396NIH HHS R01AI139675NIH HHS R01AI184466NIH HHS T32AI165396
6 · The paper itself

Abstract

While significant progress has been made in defining subsets among antigen-experienced CD8 T cells, the heterogeneity of naïve CD8 T cells remains poorly understood. Here, we identify naïve CD8 T cell subsets with superior persistence and an enhanced capacity to generate effector and memory cells, leading to more effective protection. These functionally superior naïve CD8 T cells are marked by IL-18Rα, CD73, and CXCR3, and functionally less potent naïve CD8 T cells can convert into these superior subsets through tonic TCR signaling. Their enhanced response to infections is driven by better survival of the progeny effector cells during the T cell expansion phase. This improved survival is mediated by increased Ly6C expression on effector cells derived from these functionally superior naïve cells. Collectively, our findings reveal functional heterogeneity and plasticity among naïve CD8 T cells and uncover a mechanism by which functionally superior naïve subsets drive robust CD8 T cell responses, providing a previously unrecognized layer of immune regulation.

Indexed as

CD8-Positive T-LymphocytesCell PlasticityImmunologic MemoryMemory T CellsT-Lymphocyte SubsetsAnimalsAntigens, LyMiceMice, Inbred C57BLReceptors, CXCR3Signal TransductionAntigens, LyLy-6C antigen, mouseReceptors, CXCR3

Identifiers

PMID42671388
PMCPMC13540382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.